These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24346129)

  • 1. Sequencing efforts help to refine the molecular classification of breast cancer.
    Konecny GE
    Curr Opin Obstet Gynecol; 2014 Feb; 26(1):18-20. PubMed ID: 24346129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular diagnostics in oncology].
    Imianitov EN
    Vopr Onkol; 2012; 58(2):153-63. PubMed ID: 22774518
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.
    Simpson PT; Vargas AC; Al-Ejeh F; Khanna KK; Chenevix-Trench G; Lakhani SR
    Hum Pathol; 2011 Feb; 42(2):153-65. PubMed ID: 21106225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of gene expression profile signatures in early-stage breast cancer.
    Desmedt C; Sotiriou C; Piccart-Gebhart MJ
    Cancer Invest; 2009 Jan; 27(1):1-10. PubMed ID: 19191098
    [No Abstract]   [Full Text] [Related]  

  • 5. Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancer.
    Van Tine BA
    MLO Med Lab Obs; 2014 Sep; 46(9):18, 20-1. PubMed ID: 25252395
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular classification of breast cancer: is it time to pack up our microscopes?
    Cummings MC; Chambers R; Simpson PT; Lakhani SR
    Pathology; 2011 Jan; 43(1):1-8. PubMed ID: 21240058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular diagnostics in pathology].
    Stenzinger A; Penzel R; Endris V; Weichert W
    Dtsch Med Wochenschr; 2013 May; 138(20):1061-8. PubMed ID: 23670263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification of breast tumors: toward improved diagnostics and treatments.
    Sørlie T
    Methods Mol Biol; 2007; 360():91-114. PubMed ID: 17172726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does massively parallel DNA resequencing signify the end of histopathology as we know it?
    Aparicio SA; Huntsman DG
    J Pathol; 2010 Jan; 220(2):307-15. PubMed ID: 19921711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative biomarker development for personalized medicine in breast cancer care.
    Zografos GC; Roukos DH
    Biomark Med; 2011 Feb; 5(1):73-8. PubMed ID: 21319967
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular and clinicopathological markers of prognosis in breast cancer.
    Boyle DP; McCourt CM; Matchett KB; Salto-Tellez M
    Expert Rev Mol Diagn; 2013 Jun; 13(5):481-98. PubMed ID: 23782255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular assays to predict prognosis of breast cancer.
    Paik S
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):681-2. PubMed ID: 17982408
    [No Abstract]   [Full Text] [Related]  

  • 13. Largest ever DNA methylation dataset for breast cancer completed.
    Dedeurwaerder S; Desmedt C; Calonne E
    Expert Rev Mol Diagn; 2011 Jun; 11(5):470. PubMed ID: 21842555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer gene expression profiling: clinical trial and practice implications.
    Loi S; Desmedt C; Cardoso F; Piccart M; Sotiriou C
    Pharmacogenomics; 2005 Jan; 6(1):49-58. PubMed ID: 15723605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
    Pinto AE; André S; Pereira T; Silva G; Soares J
    Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression profiles in the diagnosis and prognosis of cancer].
    Kopper L; Tímár J
    Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In practice for the pathologist: practical and technical limitations].
    Rochaix P
    Ann Pathol; 2011 Nov; 31(5 Suppl):S43-5. PubMed ID: 22054457
    [No Abstract]   [Full Text] [Related]  

  • 19. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.
    Sunami E; Vu AT; Nguyen SL; Giuliano AE; Hoon DS
    Ann N Y Acad Sci; 2008 Aug; 1137():171-4. PubMed ID: 18837943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.